ArticleMolecular therapy. Nucleic acids2019

Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway.

Chunming Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.